GHRH(1-29) Analog
Sermorelin (GHRH 1-29 NH₂) is a synthetic peptide corresponding to the first 29 amino acids of endogenous growth hormone-releasing hormone, representing the shortest fully active fragment. It stimulates the pituitary gland to produce and secrete GH in a physiological, pulsatile manner. Preclinical and clinical research has studied its role in GH deficiency models, IGF-1 elevation, and age-related GH decline. It is used as a reference GHRH agonist in growth hormone axis research.
Research Benefits
Documented areas of investigation based on peer-reviewed preclinical and clinical literature. For research reference only.
Promotes natural, pulsatile growth hormone release from the anterior pituitary.
Supports insulin-like growth factor-1 production for downstream anabolic signaling.
Studied for effects on lean mass, adipose tissue, and metabolic rate in research models.
Investigated for bone mineral density support in GH-deficient preclinical models.
Literature
Shortest fully active GHRH fragment — standard reference agonist for GH axis research
Physiological pulsatile GH secretion preserved vs. continuous GH administration
IGF-1 elevation and improved body composition in GH-deficient rodent models
Age-related GH decline reversal studied in elderly subject clinical research (Walker et al.)
Specifications
Molecular Weight
3357.93 g/mol
Sequence / Structure
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Storage Conditions
Lyophilized: −20°C, stable 24 months. Reconstituted: 4°C, use within 28 days.
Solubility
Soluble in sterile water at ≥1 mg/mL
HPLC Purity
Verified — Batch VRC-SRM-2406
Testing Lab
SGS Life Sciences · Jun 2026
Research Areas
Sermorelin is currently in stock. View pricing, sizes, and the full Certificate of Analysis on the product page.
For Research Purposes Only. Sermorelin is sold exclusively for in vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. Research highlights are summaries of published preclinical and clinical studies and do not constitute medical advice or claims of efficacy. See our Research Use Disclaimer.